LBH589 (panobinostat), a pan-HDAC inhibitor that indirectly promotes the degradation of HIF-1α, demonstrates antitumor effects in HCC, pancreatic cancer, NSCLC, and glioblastoma [217,218]. The gene discussed is HIF1A; the disease is hepatocellular carcinoma.